Related Experiment Videos
[Mesangial C3-glomerulonephritis]
Vutreshni Bolesti
|January 1, 1991
Insights
Mesangial C3-glomerulonephritis patients often present with hematuria or proteinuria. This study found no renal function impairment in 12 patients over a mean 5.7-year follow-up, indicating a potentially favorable prognosis.
Area of Science:
- Nephrology
- Immunology
Context:
- Mesangial C3-glomerulonephritis (C3G) is a rare kidney disease.
- Understanding the long-term prognosis of C3G is crucial for patient management.
Purpose:
- To evaluate the clinical course and renal function in patients with mesangial C3-glomerulonephritis.
- To assess the long-term outcomes of C3G.
Summary:
- This study followed 12 patients (7 female, 5 male, aged 16-42) with mesangial C3G for a mean of 5.7 years (range 1-18 years).
- The most common manifestations were macroscopic hematuria or low-grade proteinuria; one patient had hypertension, and only one developed nephrotic syndrome.
- Crucially, no patient experienced renal function impairment during the observation period.
Impact:
- Findings suggest that mesangial C3-glomerulonephritis may have a favorable long-term prognosis with preserved renal function.
- Highlights the importance of monitoring for specific clinical manifestations while emphasizing the potential for stable kidney function.
Abstract:
12 patients with mesangial C3-glomerulonephritis, 7 women and 5 men, aged 16-42, mean age 29.7 years, were followed up for 1-18 years, mean time 5.7 years. The disease was manifested most often by macroscopic hematuria or low degree proteinuria. Single patients had arterial hypertension. In only one patient there was a nephrotic syndrome. For the period of observation, impairment of the renal function was found in none of the patients.